This inventor holds 40 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Smithkline Beecham Corporation, Beecham Group Plc, Glaxo Group Limited. Active years: 1990-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Epping, GB (1996 - 2003)
- Harlow, GB (1990 - 2013)
Company Filing History:
27 out of 2,198 
9 out of 855 
4 out of 1,169 
Years Active: 1990-2013
Areas of Expertise:
Title: The Innovative Journey of Inventor Paul Adrian Wyman
Introduction:
Paul Adrian Wyman, a prolific inventor hailing from Harlow, GB, has left an indelible mark in the field of medicine and pharmaceuticals with his groundbreaking inventions. With an impressive portfolio of 40 patents to his name, Wyman's dedication to advancing treatments for psychotic disorders, cognitive impairments, and Alzheimer's Disease is truly commendable.
Latest Patents:
Wyman's latest patents showcase his ingenuity and commitment to developing novel compounds for medicinal purposes. The compounds of formula (I) and their salts offer new avenues for treating a range of neurological conditions. These inventions also highlight the potential for creating pharmaceutical compositions that could revolutionize healthcare practices.
Career Highlights:
Throughout his career, Wyman has lent his expertise to renowned companies such as Smithkline Beecham Corporation and Beecham Group Plc. His contributions to these organizations have undoubtedly propelled innovation in the pharmaceutical industry, leading to the development of life-changing medications and treatments. Wyman's visionary approach to drug discovery has cemented his reputation as a trailblazer in the field.
Collaborations:
Wyman's collaborations with esteemed colleagues such as Laramie Mary Gaster and Francis D King have been instrumental in driving forward his inventive projects. By fostering a spirit of teamwork and knowledge-sharing, Wyman has been able to leverage the diverse expertise of his coworkers to achieve remarkable results in the realm of pharmaceutical research and development.
Conclusion:
In conclusion, Paul Adrian Wyman stands as a testament to the power of innovation and perseverance in the realm of medicinal chemistry. His relentless pursuit of novel solutions for treating complex neurological disorders serves as an inspiration to aspiring inventors and researchers worldwide. Wyman's legacy will undoubtedly endure through his numerous patents and contributions to the field of pharmaceutical science, leaving a lasting impact on healthcare practices for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile